Exploring nanomedicine in cancer: Diagnosis, treatment and its potential applications

Abstract

This review explores the various applications of nanomedicine in cancer characterization, diagnosis, treatment and targeted therapy. Both active and passive strategies are used by nanoparticles to target cancer cells. Nanoparticles can be engineered to carry imaging agents that permit for the visualization of tumors at the molecular and mobile tiers. Techniques inclusive of magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) can be greater the use of nanoparticle evaluation sellers, providing unique records about the tumor's length, form, and location. Moreover, nanoparticles can facilitate the controlled release of drugs and increase drug release efficiency with fewer side effects. Nanomaterials such as microbubbles are used as molecular imaging agents for ultrasound imaging. A greater surface area, a higher volume proportion, and improved targeting skills are just a few of the remarkable characteristics of nanoparticles. Furthermore, because they don't harm healthy cells as much, they can functionally enter tissues and epithelium, increasing their bioavailability and half-life. Many medications are now offered or coated with nanoparticles to directly target tumors or damaged organs without endangering healthy tissues or cells. Numerous nanoparticle kinds, including dendrimers, graphene, fullerene, metallic, magnetic, polymeric, metal oxide, quantum dots, liposomes, carbon nanotubes, and graphene, may find use in the detection and therapy of cancer. Because of their antioxidant properties, nanoparticles have been shown in numerous studies to exhibit intrinsic anticancer activity and to suppress the growth of malignancies. Nanomedicine has emerged as a transformative approach in cancer treatment and diagnosis. This review covers the latest diagnostic procedures, therapeutic treatment and potential applications of nanomedices.